{"URL": "https://www.wired.com/1999/07/cells-may-grant-viral-immunity", "heading": "cells may grant viral immunity", "subheading": "a new study shows injecting specialized cells can temporarily boost immmunity. researchers hope it could lead to vaccines for cancer, herpes, and hiv. by kristen philipkoski.", "author": "kristen philipkoski", "category": "science", "type": "article", "timestamp": "07.16.1999 03:00 AM", "text": "in what could be an important step toward developing vaccines for cancer, hiv, and other viruses, a new study shows treated cells can create antibodies that temporarily boost immunity. researchers at rockefeller university in new york injected nine healthy patients with a small number of cells containing antigens, toxins that cause the body to produce antibodies. the number of t-cells, which control the production of antibodies, increased in all nine patients, and the immune effects lasted up to 90 days.read ongoing med-tech coverage - - - - - -\"we still have quite a way to go to optimize this treatment. but the fact that we were able to see immunization with relatively few cells in virtually everybody who got the injection underscores how important these cells are,\" said nina bhardwaj, associate professor for clinical investigation at rockefeller and senior author of the study.the research, which was published in the 15 july issue of the <a class=\"external-link\" data-event-click='{\"element\":\"externallink\",\"outgoingurl\":\"http://www.jci.org\"}' href=\"http://www.jci.org\" rel=\"nofollow noopener\" target=\"_blank\">journal of clinical investigation</a>, is the first to show that a single injection of mature dendritic cells can induce a significant level of immunity in people.\"it's very exciting because we proved the principle and we had a profound effect with just one injection,\" bhardwaj said.the cells have the potential to help patients with viral infections such as hiv, hepatitis, epstein-barr virus, and herpes, the researchers said. researchers have also used these cells in the past to study cancerous tumors, including melanoma.since the subjects were virus-free at the time of the test, researchers could see only how a healthy immune system would react to the cells.other researchers, while optimistic, said the test methodology is in its infancy and has several limitations. \"we and others have published papers on the effect of dendritic cells on cancer. we've seen a number of dramatic responses; the tumors went away in some patients,\" said edgar engleman, professor of pathology and medicine at the stanford university school of medicine, where the first studies began around 1992."}